labetalol has been researched along with clonidine in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (48.44) | 18.7374 |
1990's | 10 (15.63) | 18.2507 |
2000's | 11 (17.19) | 29.6817 |
2010's | 12 (18.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Akamatsu, M | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Brown, JJ; Fraser, R; Lever, AF; Morton, JJ; Robertson, JI; Rosei, EA; Trust, PM | 1 |
Gifford, RW; Tarazi, RC; Wollam, GL | 1 |
Havard, CW; Pearson, RM | 1 |
Beilin, LJ; Hurley, DM; Vandongen, R | 1 |
Kincaid-Smith, P; Thomas, GW; Whitworth, JA; Yeung, CK | 1 |
Brown, JJ; Lever, AF; Robertson, AS; Robertson, JI; Rosei, EA; Trust, PM | 2 |
Atkin, SH; Beaty, P; Cuffie, C; Jaker, MA; Quadrel, MA; Soto-Greene, ML | 1 |
Nakajima, M; Ueda, M | 1 |
Richardson, SB; Twente, S | 1 |
Kaukinen, S; Toivonen, J | 1 |
Chin, WP; Imai, S; Nakagawa, Y; Nakahara, H | 1 |
Azad, SS; Goldberg, ME; Larijani, GE; Marr, AT; Seltzer, JL; Smullens, SN | 1 |
Anderson, RJ; Reed, WG | 1 |
Ferguson, RK; Vlasses, PH | 1 |
Catapano, MS; Marx, JA | 1 |
Lopez, LM; Mehta, JL | 1 |
Meese, RB; Ram, CV | 1 |
Burris, JF | 1 |
Lund-Johansen, P | 1 |
Wallin, JD | 1 |
Lubbe, WF | 1 |
Drayer, JI; Weber, MA | 1 |
Hopkins, GA | 1 |
Prichard, BN | 1 |
Elliott, HL; Meredith, PA; Reid, JL | 1 |
Boichis, H; Brauner, A; Elazar, E; Neufeld, HN; Rabinowitz, B; Rosenthal, T | 1 |
Harron, DW; Leahey, WJ; McNeill, J; Nicholls, DP; O'Connor, PC; Shanks, RG | 1 |
Ram, CV | 1 |
Lilja, M | 1 |
Mancia, G | 1 |
Jounela, AJ; Karppanen, H; Lilja, M | 1 |
Brown, JJ; Cumming, AM; Lever, AF; Robertson, JI | 1 |
Dage, RC; Hsieh, CP | 1 |
De Kock, M; Maiter, D; Merello, L; Pendeville, P; Scholtes, JL | 1 |
Appalsamy, M; Mosqueda-Garcia, R; Robertson, D; Tseng, CJ | 1 |
Janssen, BJ; Oosting, J; Struyker-Boudier, HA; Tyssen, CM | 1 |
Gales, MA | 1 |
Arner, P; Galitzky, J; Lafontan, M; Nordenström, J | 1 |
Bertrand, O; Defraigne, JO; Demoulin, JC; Detry, O; Limet, R | 1 |
Marik, PE; Varon, J | 1 |
Bisognano, J; Izzo, JL; Moser, M | 1 |
Charlton, F; Hennessy, A; Makris, A; Xu, B | 1 |
Malaty, IA; Malaty, J | 1 |
Bobek, G; Hennessy, A; Makris, A; Xu, B | 1 |
Prescott, A; Smereck, J | 1 |
13 review(s) available for labetalol and clonidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antihypertensive drugs: clinical pharmacology and therapeutic use.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Minoxidil; Monoamine Oxidase Inhibitors; Nitroprusside; Potassium; Prazosin; Secologanin Tryptamine Alkaloids; Sympatholytics | 1977 |
Hypertensive emergencies and urgencies.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Nitroglycerin; Nitroprusside; Risk; Trimethaphan | 1986 |
Hypertensive cardiovascular emergencies.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Diuretics; Eclampsia; Emergencies; Female; Humans; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Pregnancy; Pulmonary Edema; Trimethaphan | 1985 |
Hypertension in pregnancy. Pathophysiology and management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Clonidine; Diazoxide; Diuretics; Drug Therapy, Combination; Female; Fetal Diseases; Hemodynamics; Humans; Hydralazine; Hypertension; Hypnotics and Sedatives; Labetalol; Magnesium Sulfate; Pregnancy; Pregnancy Complications, Cardiovascular; Reserpine; Sympatholytics; Tranquilizing Agents | 1984 |
Central and peripheral blockade of the sympathetic nervous system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Guanabenz; Humans; Hypertension; Indoramin; Labetalol; Methyldopa; Prazosin; Quinazolines; Reserpine; Sympathetic Nervous System; Sympatholytics | 1984 |
Drug treatment of glaucoma.
Topics: Acetazolamide; Administration, Topical; Adrenergic beta-Antagonists; Bromocriptine; Clonidine; Dronabinol; Epinephrine; Glaucoma; Humans; Labetalol; Miotics; Nadolol; Parasympathomimetics; Pilocarpine; Propanolamines; Sympathomimetics; Timolol | 1984 |
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihypertensive Agents; Asthma; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Humans; Hydralazine; Hypertension; Hypertension, Renal; Infusions, Parenteral; Kidney Failure, Chronic; Labetalol; Methyldopa; Parasympathetic Nervous System; Pheochromocytoma; Pregnancy; Pregnancy Complications, Cardiovascular; Substance Withdrawal Syndrome; Tetanus | 1984 |
Labetalol and the management of hypertension.
Topics: Adrenal Gland Neoplasms; Clonidine; Ethanolamines; Humans; Hypertension; Labetalol; Pheochromocytoma; Substance Withdrawal Syndrome | 1981 |
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Phentolamine; Prazosin; Pregnancy; Pulmonary Edema; Trimethaphan | 1984 |
Oral antihypertensives for hypertensive urgencies.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure; Captopril; Clonidine; Female; Humans; Hypertension; Labetalol; Male; Nifedipine; Randomized Controlled Trials as Topic | 1994 |
Successful management of acute aortic dissection in a heart transplant recipient.
Topics: Aged; Antihypertensive Agents; Aortic Aneurysm, Thoracic; Aortic Dissection; Clonidine; Heart Transplantation; Humans; Labetalol; Male; Postoperative Complications; Time Factors | 1997 |
The diagnosis and management of hypertensive crises.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Clonidine; Diazoxide; Enalaprilat; Female; Fenoldopam; Humans; Hypertension; Labetalol; Nicardipine; Nifedipine; Nitroprusside; Phentolamine; Pre-Eclampsia; Pregnancy; Propanolamines; Trimethaphan | 2000 |
4 trial(s) available for labetalol and clonidine
Article | Year |
---|---|
Oral labetalol versus oral clonidine in the emergency treatment of severe hypertension.
Topics: Administration, Oral; Blood Pressure; Clonidine; Diastole; Emergencies; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Systole; Time Factors | 1992 |
Clonidine premedication: a useful adjunct in producing deliberate hypotension.
Topics: Adult; Blood Pressure; Clonidine; Creatinine; Ear, Middle; Electrocardiography; Female; Heart Rate; Hemostasis, Surgical; Humans; Hypotension, Controlled; Isoflurane; Labetalol; Male; Meperidine; Middle Aged; Preanesthetic Medication; Urine | 1990 |
Comparison of labetalol and clonidine in hypertension.
Topics: Adult; Clonidine; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged | 1982 |
Effects of intravenous clonidine on the secretion of growth hormone in the perioperative period.
Topics: Adult; Blood Glucose; Clonidine; Female; Growth Hormone; Humans; Infusions, Intravenous; Insulin-Like Growth Factor I; Intraoperative Period; Labetalol; Male; Postoperative Period | 1994 |
47 other study(ies) available for labetalol and clonidine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aldosterone; Angiotensin II; Clonidine; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pheochromocytoma; Propranolol; Substance Withdrawal Syndrome | 1976 |
Treatment of severe and resistant hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clonidine; Diazoxide; Diet, Sodium-Restricted; Diuretics; Humans; Hydralazine; Hypertension; Injections, Intravenous; Labetalol; Methyldopa; Nitroprusside; Patient Dropouts; Trimethaphan; Vasodilator Agents | 1978 |
Failure of labetalol to prevent hypertension due to clonidine withdrawal.
Topics: Adult; Clonidine; Drug Combinations; Ethanolamines; Female; Humans; Hypertension; Labetalol; Substance Withdrawal Syndrome | 1979 |
Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension.
Topics: Adult; Clonidine; Diazoxide; Ethanolamines; Female; Humans; Hypertension; Injections, Intravenous; Labetalol; Male | 1979 |
Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
Topics: Administration, Oral; Adult; Clonidine; Drug Evaluation; Ethanolamines; Female; Humans; Hypertension; Injections, Intravenous; Labetalol; Male; Middle Aged; Pheochromocytoma; Substance Withdrawal Syndrome | 1976 |
Letter: Emergency treatment of hypertensive crisis following clonidine withdrawal.
Topics: Clonidine; Humans; Hypertension; Labetalol; Pheochromocytoma; Substance Withdrawal Syndrome | 1976 |
Effects of dilevalol on adrenoceptors in isolated cat arteries.
Topics: Animals; Arteries; Cats; Clonidine; Dinoprost; Electric Stimulation; Female; In Vitro Techniques; Labetalol; Male; Norepinephrine; Phenylephrine; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Vasoconstriction; Yohimbine | 1990 |
Inhibition of hypothalamic somatostatin release by beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Cells, Cultured; Clonidine; Growth Hormone; Hypothalamus; Labetalol; Male; Metoprolol; Ouabain; Pituitary Gland, Anterior; Propranolol; Rats; Rats, Inbred Strains; Somatostatin | 1990 |
Alpha-blockade and vasodilatation induced by nipradilol, arotinolol and labetalol in pithed rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Clonidine; Decerebrate State; Labetalol; Male; Phenylephrine; Prazosin; Propanolamines; Rats; Rats, Inbred Strains; Vasodilation; Yohimbine | 1985 |
Intravenous labetalol for the treatment of hypertension after carotid endarterectomy.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Calcium Channel Blockers; Clonidine; Endarterectomy, Carotid; Ephedrine; Epinephrine; Female; Heart Rate; Humans; Hypertension; Hypotension; Injections, Intravenous; Labetalol; Male; Norepinephrine; Renin; Time Factors | 1989 |
Current concepts in treatment of hypertensive urgencies.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Central Nervous System; Clonidine; Diuretics; Ganglia; Guanethidine; Humans; Hypertension; Labetalol; Minoxidil; Patient Compliance; Prazosin; Sympatholytics; Vasodilator Agents | 1986 |
Management of urgent hypertension: a comparison of oral treatment regimens in the emergency department.
Topics: Administration, Oral; Antihypertensive Agents; Captopril; Clonidine; Drug Administration Schedule; Emergency Service, Hospital; Hemodynamics; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Prazosin | 1986 |
Rebound hypertension following abrupt cessation of clonidine and metoprolol. Treatment with labetalol.
Topics: Aged; Clonidine; Humans; Hypertension; Labetalol; Male; Metoprolol; Substance Withdrawal Syndrome | 1987 |
Drugs for hypertensive emergencies.
Topics: Administration, Oral; Captopril; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nifedipine; Nitroprusside; Trimethaphan | 1985 |
Hypertensive emergencies.
Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Nitroprusside; Propranolol; Risk; Trimethaphan | 1985 |
Hemodynamic effects of antihypertensive agents.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzothiadiazines; Cardiac Output; Clonidine; Diuretics; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Risk; Sodium Chloride Symporter Inhibitors; Stroke Volume | 1983 |
Antihypertensives and their impact on renal function.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Captopril; Central Nervous System; Clonidine; Glomerular Filtration Rate; Humans; Kidney; Labetalol; Methyldopa; Prazosin; Renal Circulation; Vasodilator Agents | 1983 |
Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.
Topics: Adult; Blood Pressure; Catecholamines; Clonidine; Cyclic AMP; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Substance Withdrawal Syndrome | 1981 |
Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
Topics: Adolescent; Adult; Blood Pressure; Clonidine; Ethanolamines; Heart Rate; Humans; Indoles; Indoramin; Labetalol; Male; Norepinephrine; Posture; Renin; Sympathetic Nervous System | 1984 |
Interaction of clonidine and labetalol in hypertension.
Topics: Adult; Benzothiadiazines; Blood Pressure; Clonidine; Diuretics; Drug Interactions; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Sodium Chloride Symporter Inhibitors | 1983 |
Blood pressure variability at normal and high blood pressure.
Topics: Adolescent; Adult; Aged; Blood Pressure; Blood Pressure Determination; Clonidine; Heart Rate; Humans; Hypertension; Labetalol; Middle Aged; Monitoring, Physiologic; Nadolol; Propanolamines; Time Factors | 1983 |
Intravenous labetalol in the treatment of severe hypertension.
Topics: Adrenal Gland Neoplasms; Catecholamines; Clonidine; Ethanolamines; Humans; Hypertension; Infusions, Parenteral; Injections, Intravenous; Labetalol; Pheochromocytoma; Substance Withdrawal Syndrome | 1982 |
Direct vasodilatation by labetalol in anaesthetized dogs.
Topics: Adrenalectomy; Anesthesia; Animals; Clonidine; Diazoxide; Dogs; Ethanolamines; Female; Hemodynamics; Hydralazine; Labetalol; Male; Vagotomy; Vasodilator Agents | 1980 |
Effects of nicotine on brain stem mechanisms of cardiovascular control.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain Stem; Cardiovascular Physiological Phenomena; Cardiovascular System; Clonidine; Heart Rate; Hexamethonium; Hexamethonium Compounds; Labetalol; Male; Nicotine; Physostigmine; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley | 1993 |
Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Circadian Rhythm; Clonidine; Felodipine; Heart Rate; Hypertension; Labetalol; Male; Metoprolol; Oxazoles; Prazosin; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Rilmenidine; Thiophenes | 1993 |
Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue.
Topics: Adipose Tissue; Adult; Analysis of Variance; Clonidine; Dose-Response Relationship, Drug; Epinephrine; Ethanol; Female; Glycerol; Humans; Hydralazine; Kinetics; Labetalol; Lipid Mobilization; Male; Nitroprusside; Propranolol; Receptors, Adrenergic, alpha; Time Factors; Yohimbine | 1993 |
Hypertensive emergencies.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clonidine; Diuretics; Emergencies; Emergency Medical Services; Humans; Hypertension; Labetalol | 2006 |
Antihypertensive drugs methyldopa, labetalol, hydralazine, and clonidine improve trophoblast interaction with endothelial cellular networks in vitro.
Topics: Antihypertensive Agents; Cells, Cultured; Clonidine; Coculture Techniques; Culture Media, Conditioned; Cytokines; Endothelium, Vascular; Female; Humans; Hydralazine; In Vitro Techniques; Labetalol; Methyldopa; Trophoblasts | 2014 |
Hypertensive urgency: an important aetiology of rebound hypertension.
Topics: Adrenergic alpha-2 Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Emergencies; Herb-Drug Interactions; Humans; Hypertension; Labetalol; Male; Middle Aged; Yohimbine | 2014 |
Antihypertensive methyldopa, labetalol, hydralazine, and clonidine reversed tumour necrosis factor-α inhibited endothelial nitric oxide synthase expression in endothelial-trophoblast cellular networks.
Topics: Antihypertensive Agents; Cells, Cultured; Clonidine; Coculture Techniques; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hydralazine; Interleukin-1 Receptor-Like 1 Protein; Labetalol; Methyldopa; Nitric Oxide Synthase Type III; Trophoblasts; Tumor Necrosis Factor-alpha; Uterus | 2017 |
Hypertensive Urgency: An Undesirable Complication of a "Male Performance" Herbal Product.
Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Dietary Supplements; Electrocardiography; Emergency Service, Hospital; Humans; Hypertension; Labetalol; Male; Middle Aged; Pausinystalia | 2019 |